Evidence map›Paper›PMID 34162498›Full record

ArticleUrologic oncology2021

The centralization of bladder cancer care and its implications for patient travel distance.

Kelly R Pekala, Jonathan G Yabes, Jathin Bandari, Michelle Yu, Benjamin J Davies, Lindsay M Sabik, Jeremy M Kahn, Bruce L Jacobs

Erratum issuedAbstract read
In one paragraph

Article in Urologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effect on Travel Distance of a Statewide Regionalization Policy for Initial Breast Cancer Surgery.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kelly R PekalaDepartment of Urology. Electronic address: pekalak@upmc.edu.
Jonathan G YabesCenter for Research on Health Care; Division of General Internal Medicine, Department of Medicine.
Jathin BandariDepartment of Urology.
Michelle YuDepartment of Urology.
Benjamin J DaviesDepartment of Urology.
Lindsay M SabikCenter for Research on Health Care; Department of Health Policy and Management, Graduate School of Public Health.
Jeremy M KahnDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.
Bruce L JacobsDepartment of Urology; Center for Research on Health Care.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Patient Oriented Research and Mentoring in Critical Care Implementation ScienceK24HL133444 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAHN, JEREMY M · 2016 to 2018
$348k
NCI NIH HHS P30 CA047904NHLBI NIH HHS K24 HL133444
6 · The paper itself

Abstract

objectivesTo evaluate the impact of centralized surgical and nonsurgical care (i.e., radiation and chemotherapy) on travel distances and survival outcomes for patients with advanced bladder cancer. Bladder cancer is a disease with high mortality for which treatment access is paramount and survival is superior in patients receiving surgery at high-volume centers.

methodsUsing SEER-Medicare, we identified patients 66 years or older diagnosed with bladder cancer between 2004-2013. We categorized patients as treated with either surgical (i.e., radical cystectomy) or nonsurgical (i.e., radiation or chemotherapy) care. We fit a linear probability model to generate the predicted proportion of patients treated at the top quintile of volume over time and assessed travel distance, 1-year all-cause mortality, and 1-year bladder cancer-specific mortality over time.

resultsA total of 6,756 and 10,383 patients underwent surgical and nonsurgical care, respectively. The percentage of patients treated at high-volume centers increased over the study period for both surgical care (53% to 62%) and nonsurgical care (47% to 55%), (both P< 0.001). Median travel distance increased (11.8 to 20.3 miles) for surgical care and (6.5 to 8.3 miles) for nonsurgical care, (both P < 0.001). The 1-year adjusted all-cause mortality and 1-year adjusted bladder-cancer specific mortality decreased significantly for both surgical and nonsurgical care (both P < 0.05).

conclusionsOver time, centralization of surgical and nonsurgical care for bladder cancer patients increased, which was associated with increasing patient travel distance and decreased all-cause and bladder-cancer specific mortality.

Indexed as

AgedFemaleHealth Services AccessibilityHumansMaleMedicareSEER ProgramSurvival AnalysisTravelUnited StatesUrinary Bladder NeoplasmsBladder cancerCentralizationMortalitySEER-MedicareTravel distance

Identifiers

PMID34162498
PMCPMC8608691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.